18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial.

18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial.

OBJECTIVE: The most widely studied positron emission tomography ligand for in vivo beta-amyloid imaging is (11)C-Pittsburgh compound B ((11)C-PIB). Its availability, however, is limited by the need for an on-site cyclotron. Validation of the (18)F-labeled PIB derivative (18)F-flutemetamol could sig...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Vandenberghe, R, Van Laere, K, Ivanoiu, A, Salmon, E, Bastin, C, Triau, E, Hasselbalch, S, Law, I, Andersen, A, Korner, A, Minthon, L, Garraux, G, Nelissen, N, Bormans, G, Buckley, C, Owenius, R, Thurfjell, L, Farrar, G, Brooks, D
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	2010

Παρόμοια τεκμήρια

Binary classification of ¹⁸F-flutemetamol PET using machine learning: comparison with visual reads and structural MRI.
ανά: Vandenberghe, R, κ.ά.
Έκδοση: (2013)

Phase 1 study of the Pittsburgh compound B derivative 18F-flutemetamol in healthy volunteers and patients with probable Alzheimer disease.
ανά: Nelissen, N, κ.ά.
Έκδοση: (2009)

Longitudinal changes in 18F-Flutemetamol amyloid load in cognitively intact APOE4 carriers versus noncarriers: Methodological considerations
ανά: Emma S. Luckett, κ.ά.
Έκδοση: (2023-01-01)

Software compatibility analysis for quantitative measures of [18F]flutemetamol amyloid PET burden in mild cognitive impairment
ανά: Hugh G. Pemberton, κ.ά.
Έκδοση: (2023-05-01)

Abeta amyloid deposition in the language system and how the brain responds.
ανά: Nelissen, N, κ.ά.
Έκδοση: (2007)

Centiloid scaling for quantification of brain amyloid with [18F]flutemetamol using multiple processing methods
ανά: Mark R. Battle, κ.ά.
Έκδοση: (2018-12-01)

Establishing cutoff values for visual amyloid positivity in [18F]flutemetamol PET
ανά: Yong-Jin Park, κ.ά.
Έκδοση: (2025-01-01)

Amyloid-Targeting PET Tracer [18F]Flutemetamol Accumulates in Atherosclerotic Plaques
ανά: Sanna Hellberg, κ.ά.
Έκδοση: (2019-03-01)

Clinical significance of focal ß-amyloid deposition measured by 18F-flutemetamol PET
ανά: Si Eun Kim, κ.ά.
Έκδοση: (2020-01-01)

Clinical outcomes up to 9 years after [18F]flutemetamol amyloid-PET in a symptomatic memory clinic population
ανά: Lyduine E. Collij, κ.ά.
Έκδοση: (2023-11-01)

Plasma protein biomarkers for the prediction of CSF amyloid and tau and [18F]-flutemetamol PET scan result
ανά: Westwood, S, κ.ά.
Έκδοση: (2018)

Author Correction: Concordance in detecting amyloid positivity between 18F-florbetaben and 18F-flutemetamol amyloid PET using quantitative and qualitative assessments
ανά: Soo Hyun Cho, κ.ά.
Έκδοση: (2021-03-01)

Whole-body biodistribution and radiation dosimetry of 18F-GE067: a radioligand for in vivo brain amyloid imaging.
ανά: Koole, M, κ.ά.
Έκδοση: (2009)

Plasma Protein Biomarkers for the Prediction of CSF Amyloid and Tau and [18F]-Flutemetamol PET Scan Result
ανά: Sarah Westwood, κ.ά.
Έκδοση: (2018-12-01)

In vivo amyloid imaging in cortical superficial siderosis.
ανά: Dhollander, I, κ.ά.
Έκδοση: (2011)

Infrequent false positive [18F]flutemetamol PET signal is resolved by combined histological assessment of neuritic and diffuse plaques
ανά: Milos D. Ikonomovic, κ.ά.
Έκδοση: (2018-06-01)

Longitudinal Assessment of Amyloid-β Deposition by [18F]-Flutemetamol PET Imaging Compared With [11C]-PIB Across the Spectrum of Alzheimer’s Disease
ανά: Shizuo Hatashita, κ.ά.
Έκδοση: (2019-09-01)

Assessment of brain beta-amyloid deposition in transgenic mouse models of Alzheimer’s disease with PET imaging agents 18F-flutemetamol and 18F-florbetaben
ανά: Hye Joo Son, κ.ά.
Έκδοση: (2018-07-01)

Functional Changes in the Language Network in Response to Increased Amyloid β Deposition in Cognitively Intact Older Adults.
ανά: Adamczuk, K, κ.ά.
Έκδοση: (2014)

Anatomical based reconstruction of dynamic brain PET images using N-[11C]-methylpiperidin-4-YL-proprionate ([11C]-PMP) in elderly normals
ανά: Nelissen, N, κ.ά.
Έκδοση: (2007)

Optimized dual-time-window protocols for quantitative [18F]flutemetamol and [18F]florbetaben PET studies
ανά: Fiona Heeman, κ.ά.
Έκδοση: (2019-03-01)

Early-phase 18F-FP-CIT and 18F-flutemetamol PET were significantly correlated
ανά: Young-Sil An, κ.ά.
Έκδοση: (2021-06-01)

Temporal and anatomical distribution of 18F-flutemetamol uptake in canine brain using positron emission tomography
ανά: Taesik Yun, κ.ά.
Έκδοση: (2020-01-01)

Comparison of [18F]Flutemetamol and [11C]Pittsburgh Compound-B in cognitively normal young, cognitively normal elderly, and Alzheimer's disease dementia individuals
ανά: Val J. Lowe, κ.ά.
Έκδοση: (2017-01-01)

Automatic lesion detection and segmentation in 18F-flutemetamol positron emission tomography images using deep learning
ανά: Chan Ju Ryu
Έκδοση: (2022-12-01)

A European multicentre PET study of fibrillar amyloid in Alzheimer's disease.
ανά: Nordberg, A, κ.ά.
Έκδοση: (2013)

Comparison of qualitative and quantitative imaging characteristics of [11C]PiB and [18F]flutemetamol in normal control and Alzheimer's subjects
ανά: James M. Mountz, κ.ά.
Έκδοση: (2015-01-01)

18F-flutemetamol PET/CT imaging in the diagnosis of mild cognitive impairment and Alzheimer's disease：a preliminary study
ανά: LEI Zhe, κ.ά.
Έκδοση: (2022-07-01)

Quantitative Evaluation of 18F-Flutemetamol PET in Patients With Cognitive Impairment and Suspected Alzheimer's Disease: A Multicenter Study
ανά: Hiroshi Matsuda, κ.ά.
Έκδοση: (2021-01-01)

Polymorphism of brain derived neurotrophic factor influences β amyloid load in cognitively intact apolipoprotein E ε4 carriers.
ανά: Adamczuk, K, κ.ά.
Έκδοση: (2013)

Computed Tomography Density and β-Amyloid Deposition of Intraorbital Optic Nerve May Assist in Diagnosing Mild Cognitive Impairment and Alzheimer’s Disease: A 18F-Flutemetamol Positron Emission Tomography/Computed Tomography Study
ανά: Han Wu, κ.ά.
Έκδοση: (2022-03-01)

Cholinergic depletion and basal forebrain volume in primary progressive aphasia
ανά: Jolien Schaeverbeke, κ.ά.
Έκδοση: (2017-01-01)

Different aspects of Alzheimer’s disease-related amyloid β-peptide pathology and their relationship to amyloid positron emission tomography imaging and dementia
ανά: Dietmar Rudolf Thal, κ.ά.
Έκδοση: (2019-11-01)

Correction to: Different aspects of Alzheimer’s disease-related amyloid β-peptide pathology and their relationship to amyloid positron emission tomography imaging and dementia
ανά: Dietmar Rudolf Thal, κ.ά.
Έκδοση: (2020-08-01)

Drug development in Alzheimer’s disease: the contribution of PET and SPECT
ανά: Lieven Denis Herwig Declercq, κ.ά.
Έκδοση: (2016-03-01)

Longitudinal APOE4- and amyloid-dependent changes in the blood transcriptome in cognitively intact older adults
ανά: Emma S. Luckett, κ.ά.
Έκδοση: (2023-07-01)

Image reconstruction methods affect software-aided assessment of pathologies of [18F]flutemetamol and [18F]FDG brain-PET examinations in patients with neurodegenerative diseases
ανά: Elin Lindström, κ.ά.
Έκδοση: (2020-01-01)

Association of Alzheimer’s disease polygenic risk scores with amyloid accumulation in cognitively intact older adults
ανά: Emma S. Luckett, κ.ά.
Έκδοση: (2022-09-01)

Levels of islet amyloid polypeptide in cerebrospinal fluid and plasma from patients with Alzheimer's disease.
ανά: Nina Schultz, κ.ά.
Έκδοση: (2019-01-01)

3D shape perception in posterior cortical atrophy: a visual neuroscience perspective
ανά: Gillebert, C, κ.ά.
Έκδοση: (2015)